BRIEF published on 12/08/2025 at 15:53, 9 months 10 days ago Vanguard Group Discloses Stake in Avadel Pharmaceuticals Form 8.3 Securities Disclosure Vanguard Group Stake Details Avadel Pharmaceuticals
PRESS RELEASE published on 12/08/2025 at 15:51, 9 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.72% stake in Qualcomm Incorporated as of 05 December 2025 according to Form 8.3 filing Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure Qualcomm Incorporated
BRIEF published on 12/08/2025 at 15:51, 9 months 10 days ago Vanguard Group Discloses Position in Greencore Group plc Financial Transactions Takeover Code Vanguard Group Shareholding Disclosure Greencore Group
PRESS RELEASE published on 12/08/2025 at 15:50, 9 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.50% ownership stake in American Axle & Manufacturing Holdings, Inc. with recent dealings reported The Vanguard Group, Inc. Disclosure Dealings Ownership Stake American Axle & Manufacturing Holdings, Inc.
BRIEF published on 12/08/2025 at 15:49, 9 months 10 days ago The Vanguard Group Discloses Position in Spire Healthcare Form 8.3 Takeover Code Vanguard Group Spire Healthcare Share Disclosure
PRESS RELEASE published on 12/08/2025 at 15:48, 9 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.73% interest in Avadel Pharmaceuticals plc in accordance with Rule 8.3 of the Irish Takeover Panel Act, 1997 The Vanguard Group, Inc. Irish Takeover Panel Rule 8.3 Interest Disclosure Avadel Pharmaceuticals Plc
BRIEF published on 12/08/2025 at 15:47, 9 months 10 days ago The Vanguard Group, Inc. Discloses Position in Alphawave IP Group plc Form 8.3 Disclosure Vanguard Group Shareholding Alphawave IP
PRESS RELEASE published on 12/08/2025 at 15:46, 9 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.36% stake in Greencore Group plc as of 05/12/2025. Additional disclosure for Bakkavor Group plc. Purchase of 11,592 1p ordinary shares at 2.50 GBP per unit Vanguard Group Share Purchase Stake Disclosure Bakkavor Group Greencore Group
PRESS RELEASE published on 12/08/2025 at 15:44, 9 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses ownership of 3.58% of Spire Healthcare Group plc's relevant securities. Purchase of 7,002 securities at 1.76 GBP per unit The Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase Spire Healthcare Group Plc
BRIEF published on 12/08/2025 at 15:44, 9 months 10 days ago The Vanguard Group Discloses Stake in Dowlais Group plc Form 8.3 Takeover Code Securities Disclosure Dowlais Group Vanguard's Stake
Published on 09/18/2026 at 14:30, 2 hours 5 minutes ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/18/2026 at 13:30, 3 hours 5 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 10 hours 5 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 15 hours 40 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 16:15, 20 minutes ago Hong Kong’s Chief Executive takes to the airwaves to discuss his strategic vision for development under the city’s First Five-Year Plan
Published on 09/17/2026 at 17:40, 22 hours 55 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 22 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 9 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
